Profile
LPCN NVO VRTX REGN SGEN ARGX
Company Name Lipocine Inc. Novo Nordisk A/S Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $24.28M $373.67B $124.20B $75.33B $43.15B $39.57B
Employees 0.02K 71.88K 5.40K 14.17K 3.26K 1.15K
CEO Dr. Mahesh V. Patel Ph.D. Mr. Lars Fruergaard Jorgensen Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. David R. Epstein B.Sc., M.B.A. Mr. Timothy Van Hauwermeiren EMBA, M.Sc.
Ratings
LPCN NVO VRTX REGN SGEN ARGX
Quant Rating Score 2 3 3 4 3 1
Quant Rating Sell Neutral Neutral Buy Neutral Strong Sell
Trading
LPCN NVO VRTX REGN SGEN ARGX
Last Close $4.54 $82.62 $482.28 $697.05 $228.74 $651.3
High 52 $10.69 $146.91 $516.74 $1201.76 $228.74 $670.4
Low 52 $3.52 $78.69 $392.81 $666.85 $228.74 $356.01
Price vs. 52 Week High -57.53 % -43.76 % -6.67 % -42 % 0 % -2.85 %
Price vs. 52 Week Low 28.98 % 4.99 % 22.78 % 4.53 % 0 % 82.94 %
Total Return
LPCN NVO VRTX REGN SGEN ARGX
1 Month Return -10.28 % -5.74 % 18.46 % -2.94 % 0 % 4.83 %
3 Month Return -22.13 % -24.98 % -3.52 % -15.96 % 0 % 8.1 %
6 Month Return -8.84 % -34.43 % 1.13 % -34.93 % 0 % 34.42 %
9 Month Return -2.99 % -32.86 % 20.25 % -27.16 % 0 % 67.77 %
YTD Return -6.97 % -3.95 % 19.76 % -2.15 % 0 % 5.9 %
1 Year Return 15.52 % -30.14 % 12.45 % -25.56 % 0 % 61.46 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
LPCN NVO VRTX REGN SGEN ARGX
Dividend Yield Percentage (TTM) - 1.61 % - - - -
Dividend Paid and Capex Coverage Ration (TTM) -55.42 % 1.25 % -2.62 % 4.88 % -2.27 % -2.22 %
Dividend Per Share (TTM) - 9.9 % - - - -
Payout Ratio (TTM) - 46.6 % - - - -
Growth
LPCN NVO VRTX REGN SGEN ARGX
Asset Growth -38.73 % 30.35 % 25.23 % 13.23 % -1.21 % 44.93 %
Gross Profit Growth -670.16 % 32.32 % 9.64 % 6.49 % 22.93 % 190.7 %
Revenue Growth -670.16 % 31.26 % 10.51 % 7.76 % 24.65 % 198.56 %
Revenue 3 Year - 90.51 % 60.36 % 55.67 % 91.56 % 2071.96 %
Revenue 5 Year -257.62 % 124.2 % 219.55 % 110.3 % 215.48 % 3041.46 %
Revenue 10 Year - 233.97 % 610.45 % 549.62 % 494.04 % 9009.53 %
EBIT Growth -47.95 % 37.11 % 0 % -14.6 % 10.13 % 40.94 %
Net Income Growth -51.99 % 50.71 % 8.96 % -8.87 % 9.51 % 58.42 %
Net Income 3 Yeari Growth Per Share 51.97 % 106.79 % 34.59 % 13.48 % -763.59 % 64.01 %
Net Income 5 Yeari Growth Per Share 66.81 % 133.86 % 70.33 % 74.02 % -276.93 % -143.65 %
Net Income 10 Yeari Growth Per Share 87.32 % 299.31 % 809.6 % 871.12 % -624.16 % -857 %
Operating Income Growth -47.95 % 37.11 % 0 % -14.6 % 10.13 % 40.94 %
Operating Cash Flow Growth (CFG) 0.86 % 38.06 % -14.35 % -8.39 % 9.07 % 51.28 %
Operating 3 Year CFG 52.25 % 118.29 % 9.63 % 76.95 % -147.99 % 21.71 %
Operating 5 Year CFG 76.75 % 163.51 % 174.78 % 125.17 % -195.86 % -329.63 %
Operating 10 Year CFG 88.66 % 404.49 % 6084.35 % 713.56 % -2622.09 % -1280.2 %
EPS Growth -46.05 % -23.83 % 8.33 % -8.54 % 10.81 % 60.46 %
EPS Diluted Growth -53.17 % -23.81 % 8.35 % -9.03 % 10.81 % 60.46 %
Book Value Per Share -45.83 % 29 % 25.58 % 15.03 % -9.83 % 38.53 %
Share Holder 3 Year Equity Growth Per Share -18.23 % 75.22 % 104.06 % 137.56 % 33.72 % 94.42 %
Share Holder 5 Year Equity Growth Per Share -48.9 % 121.9 % 291.14 % 219.1 % 220.81 % 318.81 %
Share Holder 10 Year Equity Growth Per Share -96.27 % 200.81 % 1030.79 % 1286.9 % 691.19 % 3654.06 %
Dividend Per Share Growth - 26.89 % - - - -
Dividend 3 Year Growth Per Share - 64.4 % - - - -
Dividend 5 Year Growth Per Share - 80.03 % - - - -
Dividend 10 Year Growth Per Share - 292.94 % - - - -
Debt Growth - 4.74 % 44.1 % 0.06 % -23.28 % 60.95 %
Free Cash Flow Growth 1.85 % 9.17 % -16.47 % -17.11 % 3.67 % 51.98 %
Updated On 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2022 31 Dec 2023
Profitability
LPCN NVO VRTX REGN SGEN ARGX
Gross Profit Margin TTM 76.34 % 84.66 % 86.1 % 86.68 % 72.37 % 86.82 %
Return on Assets TTM -19.6 % 23.83 % -2.16 % 11.69 % -11.76 % -2.13 %
Return on Equity TTM -19.17 % 86.4 % -2.88 % 14.77 % -16.53 % -2.75 %
Return on Capital Employed TTM -27.69 % 62.74 % -1.72 % 10.89 % -16.87 % -8.98 %
Net Income Per EBT TTM 100.03 % 79.43 % -184.82 % 92.32 % 100.55 % 167.72 %
EBT Per Ebit TTM 76.6 % 100.52 % -82.68 % 118.85 % 94.01 % 15.76 %
EBIT Per Revenue TTM -66.82 % 43.84 % -2.96 % 28.32 % -36.09 % -17.08 %
Cash Flow To Debt Ratio TTM - 207.5 % -49.48 % 214.04 % -185.98 % -428.57 %
Receivables Turnover TTM - 3.89 6.06 2.29 1.98 3.45
Payables Turnover TTM 6.57 1.72 3.73 - 1.54 1.06
Inventory Turnover TTM - 1.09 1.37 0.61 0.65 0.91
Fixed Asset Turnover TTM 4643.42 % 225.8 % 422.11 % 308.76 % 256.83 % 6116.64 %
Asset Turnover TTM 38.28 % 68.08 % 47.71 % 37.61 % 34.46 % 47.09 %
Operating Cash Flow Per Share TTM -0.92 26.54 -3.27 39.47 -1.12 -2.42
Free Cash Flow Per Share TTM -0.94 15.14 -4.51 31.39 -1.62 -3.52
Cash Per Share TTM 370.68 % 1681.33 % 2528.88 % 16647.4 % 657.5 % 5163.05 %
Operating Cash Flow Sales Ratio TTM -62.42 % 43.69 % -7.94 % 29.91 % -16.85 % -6.44 %
Free Cash Flow Operating Cash Flow Ratio TTM 101.8 % 57.03 % 138.12 % 79.52 % 144.14 % 145.12 %
Cash Flow Coverage Ratios TTM - 207.5 % -49.48 % 214.04 % -185.98 % -428.57 %
Price To Free Cash Flows Ratio TTM -4.82 40.84 -106.72 22.3 -141.85 -187.36
Price To Operating Cash Flows Ratio TTM -4.91 23.12 -147.67 17.66 -203.89 -268.89
Price Cash Flow Ratio TTM -4.91 23.12 -147.67 17.66 -203.89 -268.89
Income Statement (TTM)
LPCN NVO VRTX REGN SGEN ARGX
Revenue $-0B $232.26B $9.87B $14.2B $1.96B $1.23B
Gross Profit $-0B $196.5B $8.61B $13.22B $1.55B $1.11B
Gross Profit Ratio 100% 84.6% 87.21% 93.07% 79.1% 90.39%
EBITDA $-0.02B $113.33B $4.61B $3.99B $-0.62B $-0.22B
Net Income $-0.02B $83.68B $3.62B $4.41B $-0.61B $-0.3B
EPS Diluted -3.14 9.31 13.89 38.34 -3.3 -5.16
Balance Sheet (MRQ)
LPCN NVO VRTX REGN SGEN ARGX
Long Term Debt $0B $20.53B $0.72B $2.7B $0.04B $0.02B
Total Liabilities $0B $207.93B $5.15B $7.11B $0.87B $0.44B
Total Equity $0.02B $106.56B $17.58B $25.97B $2.8B $4.1B
Total Investments $0.02B $17.5B $3.45B $13.51B $1.42B $1.18B
Total Debt $0B $27.01B $0.81B $2.7B $0.04B $0.02B
Total Assets $0.02B $314.49B $22.73B $33.08B $3.67B $4.54B
Cash Flow Statement (TTM)
LPCN NVO VRTX REGN SGEN ARGX
Net Income $-0.02B $83.68B $3.62B $3.95B $-0.61B $-0.43B
Inventory $0B $-7.42B $-0.32B $-0.27B $-0.23B $-0.08B
Dividends Paid $0B $-31.77B $0B $0B $0B $0B
Operating Cash Flow $-0.01B $108.91B $3.54B $4.59B $-0.45B $-0.42B
Capital Expenditure $-0B $-38.9B $-0.26B $-0.93B $-0.08B $-0.04B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.8035
ABCL AbCellera Biologics Inc. 3.225
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.98
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.5
ABPWW 0.05
ABSI Absci Corporation 4.6207
ABUS Arbutus Biopharma Corporation 3.38
ABVC ABVC BioPharma, Inc. 0.4705
ABVX Abivax SA American Depositary Shares 5.8325
ACAD ACADIA Pharmaceuticals Inc. 19.235
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.97
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.37
ACHV Achieve Life Sciences, Inc. 3.315
ACIU AC Immune SA 2.77
ACLX Arcellx, Inc. 68.46
ACRV Acrivon Therapeutics, Inc. Common Stock 6.44
ETFs With Exposure to LPCN
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 297.8
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 132.089
VXF Vanguard Extended Market Index Fund 0 199.068
IWC iShares Micro-Cap ETF 0.00026 131.594
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 102.12
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 102.1
DFAT Dimensional U.S. Targeted Value ETF 0.00028737 57.17
DFAC Dimensional U.S. Core Equity 2 ETF 0.00001399 35.565
VTSAX Vanguard Total Stock Market Index Fund 0 145.32
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 150.94
VITSX Vanguard Total Stock Market Index Fund 0 145.35
DFSU Dimensional US Sustainability Core 1 ETF 0.00079433 39.11
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.0000871821 102.07
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 150.95
DCOR Dimensional ETF Trust 0.00076418 66.08
VEMPX Vanguard Extended Market Index InstlPlus 0 372.49
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 272.65
Unlock